MAIA Biotechnology, Inc.
MAIA
$1.87
$0.073.89%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.47% | -30.55% | 69.19% | -10.06% | -28.94% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.31% | 27.40% | -113.89% | 22.93% | 237.15% |
| Change in Net Operating Assets | 238.84% | 1,874.22% | 99.08% | -2,138.16% | -106.77% |
| Cash from Operations | -7.53% | -10.88% | 24.76% | -30.61% | 10.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.78% | 621.07% | -91.69% | 66.35% | -11.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -52.53% | -110.34% | 80.08% | -15.67% | 56.84% |
| Cash from Financing | 12.71% | 673.05% | -92.15% | 69.33% | -6.14% |
| Foreign Exchange rate Adjustments | 111.57% | -388.17% | 72.22% | 156.84% | -172.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.61% | 131.52% | -187.32% | 195.14% | 7.14% |